VANCOUVER, BC / ACCESSWIRE / June 27, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) announces that its subsidiary EastWest Science USA has signed a mutual distributor agreement with GM Health Wholesale ("GM Health") (www.gmhempco.com), a Kentucky company and a leading manufacturer and wholesaler of CBD Tinctures, Creams, Salves and Capsules. Under the terms of this agreement GM Health will become a distributor of EastWest's products and EastWest will become a global distributor for GM Health's all-natural CBD products.
"EastWest is excited to be associating themselves with experts in the field of CBD extracts and hemp cultivation. GM Health's products will add significant value to EastWest's offering" says Rodney Gelineau, CEO of EastWest Bioscience Inc. "And we're proud that GM Health will be adding EastWest's +CBD products, currently Natural Pet Science, to their wholesale catalogue." Gelineau continues.
The addition of GM Health's products to EastWest's CBD catalogue greatly accelerates time to market for several products and introduces new and unique distribution channels via GM Health's network of independent pharmacies stretching throughout multiple states.
GM Health's production operates from a 90,000 square foot USDA accredited facility with plans to expand to 360,000 square feet of greenhouse by the end of 2020. Their high CBD hemp clones, offered by Grundy Hemp Co, typically contain 10-17% CBD content and include Uno, Dos, Tres, and The Wife strains, from their own breeding program.
GM Health's hemp extract is the first naturally extracted oil on the market which is completely free of chlorophylls and carbonic acid. Using a patented flash activated process allows the plants natural terpene profile to be preserved with the true spectrum of cannabinoids, leaving a neutral nutty, sweet flavour which is barely noticeable and mixes well into all food products and nutritional supplements.
The agreement is effective as of June 26th 2019 and continues until terminated.